Opportunity ID: 349497

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-23-246
Funding Opportunity Title: Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.394 — Cancer Detection and Diagnosis Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Jul 21, 2023
Last Updated Date: Nov 08, 2024
Original Closing Date for Applications: May 04, 2026
Current Closing Date for Applications: Nov 07, 2024
Archive Date: Dec 07, 2024
Estimated Total Program Funding:
Award Ceiling: $475,000
Award Floor:

Eligibility

Eligible Applicants: Private institutions of higher education
Independent school districts
Special district governments
Public and State controlled institutions of higher education
For profit organizations other than small businesses
County governments
City or township governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
State governments
Public housing authorities/Indian housing authorities
Native American tribal governments (Federally recognized)
Small businesses
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description:

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) encourages applications promoting transformative discoveries in cancer biology and/or oncology through the use of nanotechnology. Proposed projects should address major barriers in cancer biology and/or oncology using nanotechnology and should emphasize mechanistic studies toward fundamental understanding of nanomaterial and/or nanodevice interactions with biological systems. These studies should be performed in context of research concerning the delivery of nanoparticles and/or nano-devices to desired and intended cancer targets in vivo and/or characterization of detection and diagnostic devices in vitro. IRCN awards are expected to produce fundamental knowledge to aid future and more informed development of nanotechnology-based cancer interventions. The clinical translation of these interventions is outside of the scope of this NOFO.

Link to Additional Information: https://grants.nih.gov/grants/guide/pa-files/PAR-23-246.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH Grants Information

grantsinfo@nih.gov
Email:grantsinfo@nih.gov

Version History

Version Modification Description Updated Date
Update close date per reissued NOFO PAR-25-106. Nov 08, 2024
Jul 21, 2023

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-23-246
Funding Opportunity Title: Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.394 — Cancer Detection and Diagnosis Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Jul 21, 2023
Last Updated Date: Nov 08, 2024
Original Closing Date for Applications: May 04, 2026
Current Closing Date for Applications: Nov 07, 2024
Archive Date: Dec 07, 2024
Estimated Total Program Funding:
Award Ceiling: $475,000
Award Floor:

Eligibility

Eligible Applicants: Private institutions of higher education
Independent school districts
Special district governments
Public and State controlled institutions of higher education
For profit organizations other than small businesses
County governments
City or township governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
State governments
Public housing authorities/Indian housing authorities
Native American tribal governments (Federally recognized)
Small businesses
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description:

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) encourages applications promoting transformative discoveries in cancer biology and/or oncology through the use of nanotechnology. Proposed projects should address major barriers in cancer biology and/or oncology using nanotechnology and should emphasize mechanistic studies toward fundamental understanding of nanomaterial and/or nanodevice interactions with biological systems. These studies should be performed in context of research concerning the delivery of nanoparticles and/or nano-devices to desired and intended cancer targets in vivo and/or characterization of detection and diagnostic devices in vitro. IRCN awards are expected to produce fundamental knowledge to aid future and more informed development of nanotechnology-based cancer interventions. The clinical translation of these interventions is outside of the scope of this NOFO.

Link to Additional Information: https://grants.nih.gov/grants/guide/pa-files/PAR-23-246.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH Grants Information

grantsinfo@nih.gov
Email:grantsinfo@nih.gov

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-23-246
Funding Opportunity Title: Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.394 — Cancer Detection and Diagnosis Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jul 21, 2023
Last Updated Date: Jul 21, 2023
Original Closing Date for Applications:
Current Closing Date for Applications: May 04, 2026
Archive Date: Jun 09, 2026
Estimated Total Program Funding:
Award Ceiling: $475,000
Award Floor:

Eligibility

Eligible Applicants: For profit organizations other than small businesses
State governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Independent school districts
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
County governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
City or township governments
Private institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Small businesses
Special district governments
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.

Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) encourages applications promoting transformative discoveries in cancer biology and/or oncology through the use of nanotechnology. Proposed projects should address major barriers in cancer biology and/or oncology using nanotechnology and should emphasize mechanistic studies toward fundamental understanding of nanomaterial and/or nanodevice interactions with biological systems. These studies should be performed in context of research concerning the delivery of nanoparticles and/or nano-devices to desired and intended cancer targets in vivo and/or characterization of detection and diagnostic devices in vitro. IRCN awards are expected to produce fundamental knowledge to aid future and more informed development of nanotechnology-based cancer interventions. The clinical translation of these interventions is outside of the scope of this NOFO.
Link to Additional Information: https://grants.nih.gov/grants/guide/pa-files/PAR-23-246.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH Grants Information
grantsinfo@nih.gov
Email:grantsinfo@nih.gov

Folder 349497 Full Announcement-PAR-23-246 -> PAR-23-246-Full-Announcement.pdf

Packages

Agency Contact Information: NIH Grants Information
grantsinfo@nih.gov
Email: grantsinfo@nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-H Use for due dates on or after January 25, 2023 PKG00282641 Oct 03, 2023 Nov 18, 2024 View
FORMS-I Use for due dates on or after January 25, 2025 PKG00288596 Nov 07, 2024 Nov 09, 2024 View

Package 1

Mandatory forms

349497 RR_SF424_5_0-5.0.pdf

349497 PHS398_CoverPageSupplement_5_0-5.0.pdf

349497 RR_OtherProjectInfo_1_4-1.4.pdf

349497 PerformanceSite_4_0-4.0.pdf

349497 RR_KeyPersonExpanded_4_0-4.0.pdf

349497 PHS398_ResearchPlan_5_0-5.0.pdf

349497 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

349497 RR_Budget_3_0-3.0.pdf

349497 RR_SubawardBudget30_3_0-3.0.pdf

349497 PHS398_ModularBudget_1_2-1.2.pdf

349497 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 2

Mandatory forms

349497 RR_SF424_5_0-5.0.pdf

349497 PHS398_CoverPageSupplement_5_0-5.0.pdf

349497 RR_OtherProjectInfo_1_4-1.4.pdf

349497 PerformanceSite_4_0-4.0.pdf

349497 RR_KeyPersonExpanded_4_0-4.0.pdf

349497 PHS398_ResearchPlan_5_0-5.0.pdf

349497 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

349497 RR_Budget_3_0-3.0.pdf

349497 RR_SubawardBudget30_3_0-3.0.pdf

349497 PHS398_ModularBudget_1_2-1.2.pdf

349497 PHS_AssignmentRequestForm_4_0-4.0.pdf

2025-07-11T07:16:14-05:00

Share This Post, Choose Your Platform!

About the Author: